Powered by www.300.cn 粤ICP备17107330号-1
Powered by www.300.cn 粤ICP备17107330号-1
Connect with us
SOCIAL MEDIA CHANNELS
Luofu Wang
Luo-Fu Wang is vice-director of Department of Urology,Third Affiliated Hospital (Daping Hospital), Third Military Medical University. During his 20 years’ dedication in urology, he has carried out numerous creative scientific and clinical research, focusing on urolithiasis, urological oncology and prostate disease, especially in minimal invasive surgery of urological stone. He has published 51 articles as first author or corresponding author, including 6 in SCI cited journals.
EDUCATION:
Ph.D in urological surgery, September 1997-Dec 2000
Department of Urology, Daping Hospital, the Third Military Medical University, Chongqing, P.R. China
MS in human antamy, September 1991-July 1997
Department of Anatamy, the Third Military Medical University, Chongqing, P.R. China
BS in medicine, September 1988-July 1991
Linyi Medical College, Shandong Province, P.R. China
PROFESSIONAL APPOINTMENTS
2010.2 to present: vice-director, Department of Urology, Daping Hospital, the Third Military Medical University
2014.9 to present: professor of urological surgery, Department of Urology, Daping Hospital, the Third Military Medical University
2005.9 to 2014.8: associate professor of urological surgery, Department of Urology, Daping Hospital, the Third Military Medical University
2000.7-2005.8:Lecturer, attending surgeon of urological surgery, Department of Urology, Daping Hospital, the Third Military Medical University.
AFFILIATION AND HONORS
- Regular member: Digital Medcine Branch of Chinese Medical Association
- Regular member: Urological Committee of Chongqing Medical Association
- Regular member: Chongqing Association of Combination of Chinese Traditional and Western Medicine
- 2001 the second award of National Prize for Progress in Science and Technology
GRANTS:
- Preperation and efficacy evaluation of renal cell carcinoma targeted multifunctional nanobubbles. Supported by National Natural Science Foundation of China (01/2015-12/2018). Approval No. 81472399
- Suppressive effect of androgen receptor siRNA on prostate cancer cell proliferation by RNA interference. Supported by Chongqing Science and Technology Commision (9/2006-12/2008)
- Antitumor effect of rPB-DR(6) promotor regulated oncolytic adenovirus on prostate cancer cells. Supported by Chongqing Science and Technology Commision (10/2010-10/2013)
PUBLICATIONS IN RECENT YEARS:
1. Wang L, Zhang M, Tan K, Guo Y, Tong H, Fan X, Fang K, Li R. Preparation of Nanobubbles Carrying Androgen Receptor siRNA and Their Inhibitory Effects on Androgen-Independent Prostate Cancer when Combined with Ultrasonic Irradiation. PLOS ONE 2014; 9(5):e96586.
2. Xiaozhou Fan, Luofu Wang, Yanli Guo,et al. Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging. PLoS One. 2015;10(6):e0127419. (joint first authors)
3. Fan X, Wang L, Guo Y, Xiong X, Zhu L, Fang K. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction. Int J Nanomedicine. 2016 ;11:3585-96 (joint first authors)
4. Luofu Wang, Lang Li, Yanli Guo, Haipeng Tong, Xiaozhou Fan,Jun Ding, and Haiyun Huang. Construction and In Vitro/In Vivo Targeting of PSMA-Targeted Nanoscale Microbubbles in Prostate Cancer. Prostate, 2013; 73(11): 1147-1158
5. Xiaozhou Fan, Luofu Wang, Yanli Guo, Haipeng Tong, Lang Li,Jun Ding, and Haiyun Huang. Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft. Nanotechnology. 2013; 24(32):325102 (joint first authors)
6. Chengguo Ge, Qiansheng Li, Luofu Wang, Fengshuo Jin, Yanfeng Li, Jianghua Wan, Weihua Lan, and Peihei Liang.Management of Complete Ureteral Avulsion and Literature Review. A Report on Four Cases. J Endourol, 2011; 25(2): 323–326 (corresponding author)
7. Haipeng Tong, Luofu Wang, Yanli Guo, Lang Li,Xiaozhou Fan, Jun Ding, and Haiyun Huang. Preparation of protamine cationic nanobubbles and experimental study of their physical properties and in vivo contrast enhancement. Ultrasound Med Biol. 2013; 39(11):2147-57